Who Can Participate?
Physicians, research nurses, and research coordinators. At the heart of the community of practice concept is the idea of learning by interacting with others.


A community of practice is a group of healthcare professionals who meet to share knowledge, discuss challenges and experiences, and facilitate patient referral based on tumor type.
Since 2018, Q-CROC has established and coordinates several communities of practice in oncology clinical research.
Physicians, research nurses, and research coordinators. At the heart of the community of practice concept is the idea of learning by interacting with others.


To establish an effective system for referring patients between centers

Quickly inform all centers of ongoing trials and upcoming ones

To increase the community’s visibility among trial promoters
Launched in 2018, RÉSOT was the first community of practice implemented by Q-CROC. Today, it has more than 80 members in 16 hospital centers across Quebec. This community fosters knowledge sharing, harmonized practices, collaboration across institutions, and enhanced access to clinical trials in thoracic oncology.
Dr. Nathalie Daaboul (Hôpital Charles-Le Moyne) acts as a leader for RÉSOT.

Launched in 2023, the Melanoma Community of Practice includes nearly 60 members from several hospital centres across Quebec. It is led by Dr. Rahima Jamal (CHUM).
Launched in the fall of 2020, this Community of Practice brings together representatives from a dozen hospital centres across Quebec. It aims to foster collaboration among teams specializing in gastrointestinal oncology, facilitate the exchange of best practices, address clinical challenges, and strengthen partnerships between centres. The community also works to optimize clinical trial recruitment and improve patient access to new therapeutic approaches. Dr. Francine Aubin (CHUM) serves as the community leader.




Launched in 2024 under the leadership of Dr. Alan Spatz (Jewish General Hospital), this Community of Practice brings together experts in molecular pathology, genetics, and oncology. It promotes the integration of biomarkers and precision medicine into clinical trials while supporting knowledge sharing and the alignment of best practices.

Established in 2025, the Kidney Cancer Community of Practice, led by Dr. Michel Pavic (CHU de Sherbrooke), provides a forum for specialists to discuss complex clinical cases, share expertise, and support optimal patient care. The community also fosters collaboration among clinical research teams, promotes the development of research projects, enhances patient recruitment for clinical trials, and encourages knowledge sharing in renal oncology.
